Mammalian Target of Rapamycin (mTOR) Inhibition: Potential for Antiseizure, Antiepileptogenic, and Epileptostatic Therapy

Current Neurology and Neuroscience Reports, 05/17/2012

Clinical studies of rapamycin in human epilepsy are limited, but suggest that mammalian target of rapamycin (mTOR) inhibitors at least have antiseizure effects in tuberous sclerosis patients.

Print Article Summary Cat 2 CME Report